open access

Vol 66, No 3 (2015)
Original papers
Published online: 2015-07-01
Submitted: 2014-07-25
Accepted: 2014-11-09
Get Citation

Serum parathyroid hormone concentrations measured by chemiluminescence and electrochemiluminescence methods — are the results comparable in haemodialysis patients with chronic kidney disease?

Piotr Kuczera, Agata Maszczyk, Ewelina Machura, Ewa Kurzak, Marcin Adamczak, Andrzej Więcek
DOI: 10.5603/EP.2015.0028
·
Endokrynologia Polska 2015;66(3):219-223.

open access

Vol 66, No 3 (2015)
Original papers
Published online: 2015-07-01
Submitted: 2014-07-25
Accepted: 2014-11-09

Abstract

Introduction: Secondary hyperparathyroidism (sHPT) is one of the most common abnormalities found in patients with chronic kidney disease (CKD). Measurement of serum PTH concentrations is crucial in diagnosis and treatment of sHPT. Different methods of serum PTH measurement may provide diverse results. This may have a significant impact on the therapeutic approach if under- or over-diagnosis of sHPT occurs. The aim of this study was to compare the results of serum PTH concentrations measured with two commonly used methods — chemiluminescence (CHL) and electrochemiluminescence (ECL).

Material and methods: Seventy-seven haemodialysis patients with CKD were enrolled into the study. Blood samples were collected before haemodialysis, in the middle of the week. In all patients, serum PTH concentrations were measured using two methods: CHL and ECL.

Results: Serum PTH concentration measured with CHL was significantly higher than that assessed with ECL: 455 pg/mL (352–559) pg/mL vs. 383 pg/mL (243–523) pg/mL; p < 0.0001. Six patients from the studied cohort were treated with cinacalcet. In these patients, the serum PTH concentration was also significantly higher when measured with CHL than with ECL: 755 pg/mL (294–1216) pg/mL and 607 pg/mL (199–1015 pg/mL); p = 0.027, respectively). In three cases serum PTH concentration assessed with CHL method exceeded 300 pg/mL, whereas when measured with ECL it was below 300 pg/mL. Lower serum PTH concentrations could give the rationale to lower cinacalcet dose or to stop such treatment.

Conclusions: 1. Serum PTH concentrations in haemodialysis patients with CKD measured by CHL and ECL methods differ significantly. 2. The choice of method for measurement of serum PTH concentration in these patients may have important clinical implications. (Endokrynol Pol 2015; 66 (3): 219–223)

Abstract

Introduction: Secondary hyperparathyroidism (sHPT) is one of the most common abnormalities found in patients with chronic kidney disease (CKD). Measurement of serum PTH concentrations is crucial in diagnosis and treatment of sHPT. Different methods of serum PTH measurement may provide diverse results. This may have a significant impact on the therapeutic approach if under- or over-diagnosis of sHPT occurs. The aim of this study was to compare the results of serum PTH concentrations measured with two commonly used methods — chemiluminescence (CHL) and electrochemiluminescence (ECL).

Material and methods: Seventy-seven haemodialysis patients with CKD were enrolled into the study. Blood samples were collected before haemodialysis, in the middle of the week. In all patients, serum PTH concentrations were measured using two methods: CHL and ECL.

Results: Serum PTH concentration measured with CHL was significantly higher than that assessed with ECL: 455 pg/mL (352–559) pg/mL vs. 383 pg/mL (243–523) pg/mL; p < 0.0001. Six patients from the studied cohort were treated with cinacalcet. In these patients, the serum PTH concentration was also significantly higher when measured with CHL than with ECL: 755 pg/mL (294–1216) pg/mL and 607 pg/mL (199–1015 pg/mL); p = 0.027, respectively). In three cases serum PTH concentration assessed with CHL method exceeded 300 pg/mL, whereas when measured with ECL it was below 300 pg/mL. Lower serum PTH concentrations could give the rationale to lower cinacalcet dose or to stop such treatment.

Conclusions: 1. Serum PTH concentrations in haemodialysis patients with CKD measured by CHL and ECL methods differ significantly. 2. The choice of method for measurement of serum PTH concentration in these patients may have important clinical implications. (Endokrynol Pol 2015; 66 (3): 219–223)

Get Citation

Keywords

parathyroid hormone; secondary hyperparathyroidism; haemodialysis; chemiluminescence; electrochemiluminescence; cinacalcet

Supplementary Files (1)
Niezatytułowany
Download
23KB
About this article
Title

Serum parathyroid hormone concentrations measured by chemiluminescence and electrochemiluminescence methods — are the results comparable in haemodialysis patients with chronic kidney disease?

Journal

Endokrynologia Polska

Issue

Vol 66, No 3 (2015)

Pages

219-223

Published online

2015-07-01

DOI

10.5603/EP.2015.0028

Bibliographic record

Endokrynologia Polska 2015;66(3):219-223.

Keywords

parathyroid hormone
secondary hyperparathyroidism
haemodialysis
chemiluminescence
electrochemiluminescence
cinacalcet

Authors

Piotr Kuczera
Agata Maszczyk
Ewelina Machura
Ewa Kurzak
Marcin Adamczak
Andrzej Więcek

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl